SCHEMBL15616197

SCHEMBL15616197

C=C(C)CCCOc1cc(C)c(Br)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ LMNA P02545 4/20 0.42
▸ HPGD P15428 2/20 0.40
▸ TSHR P16473 5/20 0.40
▸ MCL1 Q07820 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ STAT3 P40763 1/20 0.38
▸ NOD2 Q9HC29 1/20 0.38
▸ TP53 P04637 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ THRB P10828 2/20 0.35
▸ THRA P10827 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SETD1B Q9UPS6 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15464255 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL28027411 0.80 ALDH1A1 (0.54) ALDH1A1LMNAHPGDTSHRMAPT
SCHEMBL15471447 0.80 ALDH1A1 (0.41) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL11504186 0.79 MCL1 (0.58) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL78064 0.78 ALDH1A1 (0.47) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL11504215 0.78 ALDH1A1 (0.49) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL15464945 0.78 ALDH1A1 (0.39) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL15473939 0.78 ALDH1A1 (0.39) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL15464936 0.77 MCL1 (0.51) ALDH1A1LMNAHPGDTSHRMCL1
SCHEMBL16523502 0.76 ALDH1A1 (0.45) ALDH1A1LMNAHPGDTSHRMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2880028-B1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME (US) 2020-09-30 — — EP disclosed
WO-2014022528-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2014-02-06 — — WO disclosed
Send feedback